mesalamine has been researched along with cyclosporine in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (34.00) | 18.2507 |
| 2000's | 13 (26.00) | 29.6817 |
| 2010's | 19 (38.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goldman, DH; Lawson, GM; Perrault, J; Sandborn, WJ | 1 |
| Doe, WF; Elsbury, S; Hapel, AJ; Kobayashi, M; Pullman, WE | 1 |
| Doe, WF; Pullman, WE | 1 |
| Stark, ME; Tremaine, WJ | 1 |
| Gendre, JP | 1 |
| Ament, ME; Vargas, JH | 1 |
| van Hogezand, RA | 1 |
| Batts, KP; Harrison, JM; Lawson, GM; Sandborn, WJ; Schroeder, KW; Steiner, BL; Tremaine, WJ; Zinsmeister, AR | 1 |
| Archambault, A; Feagan, BG; Fedorak, RN; Gillies, R; Groll, A; Kinnear, D; Laupacis, A; McDonald, JW; Rochon, J; Saibil, F | 1 |
| Chakravarty, BJ | 1 |
| Brynskov, J; Rasmussen, SN | 1 |
| Ekström, GM | 1 |
| Tytgat, GN; van Deventer, SJ | 1 |
| Hosoya, T; Kaito, K; Kobayashi, M; Otsubo, H; Sekita, T; Shimada, T | 1 |
| Baert, F; Rutgeerts, P | 1 |
| Kougo, Y | 1 |
| Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P | 1 |
| Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG | 1 |
| Karp, LC; Plevy, SE; Rowe, FA; Targan, SR; Vasiliauskas, EA; Walker, JH | 1 |
| Ando, T; Binion, DG; Imada, A; Ina, K; Kusugami, K; Nishio, Y; Shimada, M; Tsuzuki, T | 1 |
| Cohen, RD | 1 |
| Löfberg, R | 1 |
| Hirano, E; Ishii, H; Kishikawa, H; Morishita, T; Nakano, M; Nishida, J | 1 |
| Bischoff, SC; Fleig, W; Reissmann, A | 1 |
| Lakatos, L; Lakatos, PL | 1 |
| Hanauer, SB | 1 |
| Kornbluth, A; Swaminath, A | 1 |
| Burakoff, R | 1 |
| Cury, DB; Moss, AC | 1 |
| Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T | 1 |
| Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
| Meier, J; Sturm, A | 1 |
| Xinmei, Z; Yan, C | 1 |
| Barreiro-de-Acosta, M; Campos-Franco, J; Losada-Ares, L; Pérez-Pampín, E | 1 |
| Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J | 1 |
| Actis, GC; Pellicano, R; Rizzetto, M; Rosina, F | 1 |
| Atreya, R; Neumann, H; Neurath, MF | 1 |
| Erichsen, Jv; Hessmann, M; Hoffmeyer, A; Pahl, A; Sann, H | 1 |
| Blonski, W; Buchner, AM; Lichtenstein, GR | 1 |
| Cabré, E; Calafat, M; Domènech, E; Mañosa, M | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Aloi, M; Birimberg-Schwartz, L; Bronsky, J; Buderus, S; Fell, JM; Hojsak, I; Koletzko, S; Miele, E; Russell, RK; Shaoul, R; Turner, D; Veereman, G | 1 |
| Choi, CH; Han, DS; Jung, Y; Kim, ES; Kim, YS; Lee, BI; Lee, H; Moon, W; Park, DI; Yoon, YS | 1 |
| Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž | 1 |
| Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F | 1 |
22 review(s) available for mesalamine and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
[Current medical treatment of hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Mesalamine; Sulfasalazine | 1994 |
Medical therapy for ulcerative colitis in childhood.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Child; Child, Preschool; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Infant; Intestinal Mucosa; Mercaptopurine; Mesalamine; Sulfasalazine | 1994 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Clinical pharmacology in gastroenterology: development of new forms of treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Delayed-Action Preparations; Denmark; History, 20th Century; Humans; Immunosuppressive Agents; Mesalamine | 1996 |
[Drug treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome | 1998 |
New strategies in the management of inflammatory bowel disease.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Glucocorticoids; Humans; Immunity, Mucosal; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prevalence; Tumor Necrosis Factor-alpha | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors | 1999 |
Evolving medical therapies for ulcerative colitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antineoplastic Agents; Budesonide; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferons; Mesalamine; Treatment Outcome | 2002 |
Review article: medical treatment of mild to moderately active Crohn's disease.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mesalamine; Rectal Diseases; Sulfasalazine | 2003 |
[Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Severity of Illness Index | 2007 |
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Therapy; Colitis, Ulcerative; Cyclosporine; Forecasting; Humans; Immunosuppressive Agents; Mesalamine; Patient Satisfaction | 2008 |
Optimizing drug therapy in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure | 2007 |
Current treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series.
Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Young Adult | 2012 |
[Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Algorithms; Anti-Inflammatory Agents; Azathioprine; Calcineurin Inhibitors; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mesalamine; Proctocolectomy, Restorative; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha | 2012 |
Treatment of ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha | 2014 |
[Second Korean Guideline for the Management of Ulcerative Colitis].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; C-Reactive Protein; Colitis, Ulcerative; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Parenteral Nutrition; Prednisolone; Severity of Illness Index; Steroids; Tumor Necrosis Factor-alpha | 2017 |
Inflammatory Bowel Disease - Non-biological treatment.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome | 2020 |
2 trial(s) available for mesalamine and cyclosporine
| Article | Year |
|---|---|
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Enema; Female; Humans; Mesalamine; Middle Aged; Placebos; Salicylates | 1994 |
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.
Topics: Adult; Aminosalicylic Acids; Crohn Disease; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mesalamine; Prednisone; Treatment Outcome | 1994 |
26 other study(ies) available for mesalamine and cyclosporine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis.
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Colon; Cyclosporine; Female; Humans; Mesalamine; Methylprednisolone; Sulfasalazine | 1992 |
Enhanced mucosal cytokine production in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Cyclosporine; Fluorescent Antibody Technique; Granulocyte Colony-Stimulating Factor; Growth Substances; Humans; Hydrocortisone; Inflammatory Bowel Diseases; Interleukins; Intestinal Mucosa; Mesalamine; Neutrophils; RNA Probes; RNA, Messenger | 1992 |
IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons.
Topics: Aminosalicylic Acids; Colonic Neoplasms; Cyclosporine; Humans; Hydrocortisone; Inflammatory Bowel Diseases; Interleukin-2; Intestinal Mucosa; Leukocytes, Mononuclear; Mesalamine | 1992 |
Predictors and the rate of medical treatment failure in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Discriminant Analysis; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Risk Factors; Steroids; Treatment Failure | 1993 |
Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid.
Topics: Animals; Budesonide; Colitis; Colon; Cyclosporine; Disease Models, Animal; Female; Intestinal Mucosa; Mesalamine; Organ Size; Oxazolone; Peroxidase; Rats; Time Factors | 1998 |
Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Male; Mesalamine | 1998 |
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure | 2000 |
Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Mesalamine; Middle Aged; Prognosis; Retrospective Studies; Steroids | 2000 |
Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; In Vitro Techniques; Intestinal Mucosa; Male; Mesalamine; Neutrophils; Prednisolone; Suppressor Factors, Immunologic; T-Lymphocytes | 2002 |
Ulcerative colitis associated with aplastic anemia.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Examination; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Male; Mesalamine; Prednisolone; Remission Induction; Treatment Outcome | 2003 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome | 2010 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Fatal Outcome; Humans; Male; Mesalamine; Moyamoya Disease; Nephrotic Syndrome; Prednisone; Severity of Illness Index; Young Adult | 2012 |
Avascular necrosis of the knees and ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Cholecalciferol; Colitis, Ulcerative; Cyclosporine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Knee Joint; Male; Mesalamine; Osteonecrosis; Pain; Platelet Aggregation Inhibitors; Radiography; Simvastatin; Vitamins | 2011 |
Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Colon; Cyclosporine; Dextran Sulfate; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mesalamine; Mice; Mice, Inbred BALB C; Receptors, Prostaglandin E, EP4 Subtype; Thioguanine | 2013 |
[Acute pericarditis associated with oral or topical mesalazine therapy in patients with ulcerative colitis].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chest Pain; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ileostomy; Male; Mesalamine; Pericarditis; Postoperative Complications; Suppositories | 2014 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Mesalamine; Retrospective Studies | 2016 |
Cutaneous side effects caused by treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha | 2016 |